Marking a vital milestone for Vertex and Charles River : vim

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

Related Keywords

United States , American , Jamesc Foster , , Drug Administration , Health Products Regulatory Authority , Charles River Laboratories International Inc , European Medicines Agency , Charles River Laboratories International , Charles River , North American , Chief Executive Officer , Blood , Fell , Rispr , Wood , Gene , Manufacturing ,